Emerging research highlights the transformative potential of m6A RNA modification in the diagnosis and treatment of cardiovascular diseases (CVDs).

In Alzheimer's disease, the leading cause of dementia, microglia-the brain's immune defenders-can act as both protectors and ...

CorriXR Therapeutics, Inc., an oncology-focused biotherapeutics company pioneering a novel gene editing platform to overcome drug resistance in solid tumors, today announced the publication of a ...

International research team identifies distinct population of neuroprotective immune cells of the central nervous system ...

Second agreement signed with Novartis to develop novel degraders for immune-mediated diseases, providing upfront payment of $120 million plus option maintenance payments, and eligibility for option ...

For example, naïve T cells increase in size before undergoing a burst of proliferation, while liver and fat cells enlarge or contract in response to nutrient availability. In these cases, size changes ...

Cells are regularly faced with environmental stresses that may damage or destroy them. To survive, they quickly adjust their ...

A molecular switch in breast cancer cells reprograms the genetic production line towards tumor growth and stress resistance.